rs563641001

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The ENST00000391842.6(PTOV1):​c.20C>A​(p.Ala7Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00173 in 1,095,420 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A7V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0084 ( 14 hom., cov: 31)
Exomes 𝑓: 0.00068 ( 12 hom. )

Consequence

PTOV1
ENST00000391842.6 missense

Scores

3
2
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.242

Publications

0 publications found
Variant links:
Genes affected
PTOV1 (HGNC:9632): (PTOV1 extended AT-hook containing adaptor protein) This gene encodes a protein that was found to be overexpressed in prostate adenocarcinomas. The encoded protein was found to interact with the lipid raft protein flotillin-1 and shuttle it from the cytoplasm to the nucleus in a cell cycle dependent manner. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Feb 2015]
PTOV1-AS1 (HGNC:44174): (PTOV1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002914995).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00844 (1252/148408) while in subpopulation AFR AF = 0.0292 (1194/40928). AF 95% confidence interval is 0.0278. There are 14 homozygotes in GnomAd4. There are 597 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTOV1NM_001305105.2 linkc.20C>A p.Ala7Asp missense_variant Exon 1 of 13 NP_001292034.1 Q86YD1-1
PTOV1NM_001394010.1 linkc.20C>A p.Ala7Asp missense_variant Exon 1 of 12 NP_001380939.1
PTOV1NM_017432.5 linkc.20C>A p.Ala7Asp missense_variant Exon 1 of 13 NP_059128.2 Q86YD1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTOV1ENST00000391842.6 linkc.20C>A p.Ala7Asp missense_variant Exon 1 of 12 5 ENSP00000375717.1 Q86YD1-1

Frequencies

GnomAD3 genomes
AF:
0.00842
AC:
1249
AN:
148298
Hom.:
14
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0292
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00261
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00321
Gnomad NFE
AF:
0.0000300
Gnomad OTH
AF:
0.00739
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
6
AF XY:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
GnomAD4 exome
AF:
0.000682
AC:
646
AN:
947012
Hom.:
12
Cov.:
32
AF XY:
0.000580
AC XY:
258
AN XY:
444610
show subpopulations
African (AFR)
AF:
0.0301
AC:
559
AN:
18594
American (AMR)
AF:
0.00300
AC:
13
AN:
4338
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8786
East Asian (EAS)
AF:
0.00
AC:
0
AN:
12232
South Asian (SAS)
AF:
0.00
AC:
0
AN:
18346
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
11878
Middle Eastern (MID)
AF:
0.000910
AC:
2
AN:
2198
European-Non Finnish (NFE)
AF:
0.0000144
AC:
12
AN:
836204
Other (OTH)
AF:
0.00174
AC:
60
AN:
34436
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
32
65
97
130
162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00844
AC:
1252
AN:
148408
Hom.:
14
Cov.:
31
AF XY:
0.00825
AC XY:
597
AN XY:
72392
show subpopulations
African (AFR)
AF:
0.0292
AC:
1194
AN:
40928
American (AMR)
AF:
0.00260
AC:
39
AN:
14986
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3408
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5076
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9408
Middle Eastern (MID)
AF:
0.00345
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
0.0000300
AC:
2
AN:
66556
Other (OTH)
AF:
0.00730
AC:
15
AN:
2054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
64
128
193
257
321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00687
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 21, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.20C>A (p.A7D) alteration is located in exon 1 (coding exon 1) of the PTOV1 gene. This alteration results from a C to A substitution at nucleotide position 20, causing the alanine (A) at amino acid position 7 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.64
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.023
T;T;T
Eigen
Benign
-0.10
Eigen_PC
Benign
-0.090
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.50
T;.;.
MetaRNN
Benign
0.0029
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;N;N
PhyloP100
-0.24
PrimateAI
Pathogenic
0.92
D
PROVEAN
Benign
-0.63
N;.;.
REVEL
Benign
0.073
Sift
Pathogenic
0.0
D;.;.
Sift4G
Uncertain
0.027
D;D;D
Polyphen
0.96
P;P;P
Vest4
0.24
MutPred
0.17
Loss of methylation at R5 (P = 0.064);Loss of methylation at R5 (P = 0.064);Loss of methylation at R5 (P = 0.064);
MVP
0.36
MPC
0.57
ClinPred
0.55
D
GERP RS
3.5
PromoterAI
0.068
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.9
Varity_R
0.57
gMVP
0.38
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs563641001; hg19: chr19-50354605; COSMIC: COSV109411865; COSMIC: COSV109411865; API